Lipid Profile Analysis — Mr. Zeher Ali Mondal (50 y/o Male)

Results Summary

Diagnosis

• Elevated LDL-C (172 mg/dL — nearly 72% above the < 100 mg/dL target)
• Elevated Total Cholesterol (264 mg/dL)
• Elevated Non-HDL Cholesterol (195 mg/dL — 65 above goal)
• Triglycerides and HDL are within acceptable ranges (HDL of 69 is actually protective)

ASCVD Risk Assessment

• Blood pressure
• Smoking status
• Diabetes status
• Family history of premature ASCVD

"If LDL-C ≥ 190 mg/dL, high-intensity statin recommended regardless of ASCVD risk" — though this patient is at 172 mg/dL, it is close. Per AHA/ACC 2019: patients with LDL-C ≥ 160 mg/dL (as here) are considered borderline-to-intermediate risk even without other risk factors, and a statin is strongly warranted.

• Moderate risk: LDL goal < 100, Non-HDL < 130
• High risk: LDL goal < 70, Non-HDL < 100

Management

1. Non-Pharmacological (Therapeutic Lifestyle Changes — First-line for all)

2. Pharmacological Therapy

• Expected LDL after treatment: ~80–90 mg/dL → within high-risk goal (< 100 mg/dL)

Each 39 mg/dL (1 mmol/L) reduction in LDL-C is associated with a 22% reduction in cardiovascular events. — Goldman-Cecil Medicine

• Ezetimibe 10 mg daily — additive ~15–20% LDL lowering, well tolerated
• PCSK9 inhibitors (alirocumab, evolocumab) — reserved for very high-risk patients or statin intolerance

• Fenofibrate or omega-3 fatty acids (currently TG is 114 — no indication yet)

3. Monitoring

• Repeat fasting lipid profile in 6–8 weeks after starting statin
• Baseline LFTs and CK before starting; recheck at 3 months
• Annual lipid panel once target achieved
• Screen for secondary causes: TSH (hypothyroidism), fasting glucose/HbA1c (diabetes), renal function

Key Clinical Notes

1. HDL of 69 is protective — this reduces overall cardiovascular risk somewhat, but does not negate the need to treat elevated LDL.
2. Non-HDL of 195 mg/dL is a co-primary target — it includes all atherogenic particles (LDL + VLDL + IDL + Lp(a)) and must be brought to < 130 mg/dL.
3. Cardiovascular history and family history are critical for final risk stratification and intensity of treatment.
4. Statin myopathy — warn patient about muscle aches; if CK > 10× ULN, stop statin.
5. Consider checking Lp(a) once if there's a strong family history of premature ASCVD — it is not modified by statins.

Report Analysis — Sahanaj Sultana, 24Y/F

Abnormal Values Summary

Clinical Interpretation

1. Iron Deficiency Anaemia (IDA) — Primary Finding

• Hb 11.9 g/dL (mild anaemia in a premenopausal woman)
• Low MCHC (27.1) → hypochromia
• Low MCH (25.9) → reduced haemoglobin per cell
• Elevated RDW-CV (15.7%) and RDW-SD (55.2) → anisocytosis (hallmark of IDA)
• Elevated MPV + PDW + PLCR → reactive thrombocytosis (platelet activation common in IDA)

"RDW is often elevated, a measure of anisocytosis... Classical microcytosis and hypochromia are features of established iron deficiency." — Harrison's, 22nd Ed.

2. Eosinophilia — Secondary Finding

• Absolute eosinophil count: 1.32 × 10³/µL → this is mild eosinophilia (0.5–1.5 × 10⁹/L = mild range)
• In a young woman from West Bengal (Burdwan), the most common cause is intestinal parasitic infection (helminthiasis — Ascaris, hookworm, Toxocara, Strongyloides)
• Other causes: allergic conditions (asthma, atopic dermatitis, allergic rhinitis), drug reactions

"Secondary eosinophilia due to reactive causes (e.g., allergies, asthma, parasitic infection, drug reaction) is far more common than clonal eosinophilia." — Tietz Textbook of Laboratory Medicine, 7th Ed.

3. Elevated Serum Globulin (3.92 g/dL)

4. Dyslipidaemia

• LDL 136 mg/dL, Total Cholesterol 208 mg/dL — mildly elevated
• In a 24-year-old woman without known ASCVD, the 10-year cardiovascular risk is very low
• Management is lifestyle-first; statins are generally deferred unless other risk factors are present

Management Plan

A. Iron Deficiency Anaemia

• Serum ferritin (gold standard — < 30 µg/L confirms IDA)
• Serum iron + TIBC / transferrin saturation
• Peripheral blood smear (microcytes, pencil cells, target cells)

• Ferrous sulfate 200 mg (containing ~65 mg elemental iron) — once daily on alternate days (alternate-day dosing maximises absorption by avoiding hepcidin surge)
• Take on an empty stomach or with orange juice (natural vitamin C) to enhance absorption
• Avoid taking with tea, calcium, antacids (reduce absorption)
• Duration: minimum 3 months after Hb normalises to replenish stores

"An alternate-day schedule maximises iron absorption... Addition of 80 mL of orange juice maximises absorbed fraction." — Harrison's, 22nd Ed.

• Expect reticulocyte rise in 1 week, Hb increase ≥1 g/dL by 2 weeks; if not → investigate for non-compliance, ongoing blood loss, or malabsorption

• Menstrual history — heavy/prolonged periods? (most common cause in this age group)
• If menorrhagia → Gynaecology referral; consider combined OCP, tranexamic acid
• Stool occult blood (if GI bleeding suspected)
• Dietary assessment

• Increase iron-rich foods: green leafy vegetables, jaggery, sesame seeds, meat/fish
• Pair with Vitamin C–rich foods; avoid tea/coffee with meals

B. Eosinophilia — Parasitic Screen & Management

1. Stool microscopy × 3 samples (different days) — for ova, cysts, parasites
2. Stool for Strongyloides (Baermann technique if available)
3. Serology: Toxocara ELISA if stool negative and eosinophilia persists
4. Total IgE level (to assess allergic vs. parasitic cause)
5. Chest X-ray (if pulmonary eosinophilia suspected — Löffler's syndrome)

• Albendazole 400 mg single dose (for Ascaris, hookworm, Trichuris)
• Or Mebendazole 500 mg single dose
• If Strongyloides suspected: Ivermectin 200 µg/kg/day × 2 days
• Recheck eosinophil count in 4–6 weeks

C. Dyslipidaemia (LDL 136 / TC 208)

• No statin indicated at this time
• Lifestyle intervention only:
  • Reduce saturated fat (fried foods, dairy fat, red meat)
  • Increase fibre (oats, legumes, fruits)
  • Regular aerobic exercise (150 min/week)
  • Maintain healthy weight
• Recheck fasting lipid profile in 1 year
• Rule out secondary causes of dyslipidaemia: TSH (hypothyroidism — also contributes to anaemia), fasting glucose, renal function

D. Elevated Serum Globulin

• Likely reactive (chronic infection/parasitic infestation)
• Will likely resolve with treatment of underlying parasitic cause
• If persistently elevated after treatment → check serum protein electrophoresis (SPEP) to rule out monoclonal gammopathy

Summary Action Plan